KP Tissue Inc
TSX:KPT
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
CA |
KP Tissue Inc
TSX:KPT
|
81.1m CAD | 0 | ||
US |
Procter & Gamble Co
NYSE:PG
|
390.2B USD | 17.7 | ||
US |
Colgate-Palmolive Co
NYSE:CL
|
76.5B USD | 17.6 | ||
US |
Kimberly-Clark Corp
NYSE:KMB
|
44.4B USD | 13.1 | ||
UK |
Reckitt Benckiser Group PLC
LSE:RKT
|
31.5B GBP | 8 | ||
DE |
Henkel AG & Co KGaA
XETRA:HEN3
|
34.9B EUR | 10.1 | ||
US |
Church & Dwight Co Inc
NYSE:CHD
|
26B USD | 21.5 | ||
JP |
Unicharm Corp
TSE:8113
|
2.9T JPY | 13.9 | ||
SE |
Essity AB (publ)
STO:ESSITY B
|
189.5B SEK | 8.2 | ||
US |
Clorox Co
NYSE:CLX
|
16.3B USD | 15.8 | ||
ID |
Unilever Indonesia Tbk PT
IDX:UNVR
|
124.4T IDR | 18.8 |
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.